Clinical Trials
77
Active:3
Completed:40
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:3
Phase 2:8
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (55 trials with phase data)• Click on a phase to view related trials
Not Applicable
39 (70.9%)Phase 2
8 (14.5%)Phase 1
3 (5.5%)Phase 3
2 (3.6%)Phase 4
2 (3.6%)Early Phase 1
1 (1.8%)Coronary Bifurcations With Ischaemia and Flow Assessment
Recruiting
- Conditions
- Coronary Bifurcation Lesions
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- University of East Anglia
- Target Recruit Count
- 24
- Registration Number
- NCT06971718
- Locations
- 🇬🇧
Norwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom
Pilot of Cognitive Stimulation Therapy for Pre-frail Stroke Survivors
Not Applicable
Completed
- Conditions
- StrokeFrailtyCarers
- First Posted Date
- 2024-12-13
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- University of East Anglia
- Target Recruit Count
- 5
- Registration Number
- NCT06733103
- Locations
- 🇬🇧
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
Phase 2
Recruiting
- Conditions
- Embolic Stroke of Undetermined SourceAtrial Fibrillation New Onset
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- University of East Anglia
- Target Recruit Count
- 100
- Registration Number
- NCT06715449
- Locations
- 🇬🇧
Addenbrookes Hospital, Cambridge, Cambridgeshire, United Kingdom
The Role of SGLT2i in Management of Moderate AS
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- University of East Anglia
- Target Recruit Count
- 104
- Registration Number
- NCT06469645
- Locations
- 🇬🇧
Norfolk and Norwich University Hospital, Norwich, Norfolk, United Kingdom
SCED - Wisdom Enhancement for Post-Stroke Depression
Not Applicable
Active, not recruiting
- Conditions
- Post-stroke Depression
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- University of East Anglia
- Target Recruit Count
- 3
- Registration Number
- NCT06451965
- Locations
- 🇬🇧
University of East Anglia, Norwich, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
News
Rapamycin Shows Promise as Anti-Aging Drug Matching Benefits of Calorie Restriction in Comprehensive Study
A large meta-analysis of 167 studies across eight vertebrate species found that rapamycin extends lifespan as effectively as dietary restriction and intermittent fasting.